Showing results (311-320 of 334) with videos related to

Sort By:
Pageof 34
Drug and Alcohol Review|October 7, 2024
Provider costs of treating opioid dependence with extended-release buprenorphine in AustraliaStella Settumba, Jeyran Shahbazi, Marianne Byrne, et al.
Drug and Alcohol Review|October 4, 2018
Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependenceSuzanne Nielsen, Nicholas Lintzeris, Bridin Murnion, et al.
Drug and Alcohol Review|December 16, 2022
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019Emma Black, Kristie Mammen, Rachel M Deacon, et al.
BMC Psychiatry|March 3, 2024
A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocolAnjali K Bhardwaj, Llew Mills, Michael Doyle, et al.
The International Journal on Drug Policy|March 4, 2025
Bridging the evidence and the politics: Implementation trial of supervised injectable opioid treatment (SIOT) in AustraliaAlison Ritter, James Bell, John Strang, et al.
BMJ Open|February 7, 2025
Trial protocol of an open-label pilot study of oral naltrexone-bupropion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)Krista J Siefried, Liam Acheson, Brendan Clifford, et al.
BMJ Open|August 3, 2024
Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and costCraig Rodgers, Krista J Siefried, Alison Ritter, et al.
Addiction (Abingdon, England)|June 29, 2021
Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settingsAdrian J Dunlop, Bethany White, Jillian Roberts, et al.
JAMA Internal Medicine|July 16, 2019
Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical TrialNicholas Lintzeris, Anjali Bhardwaj, Llewellyn Mills, et al.
Drug and Alcohol Review|June 3, 2025
Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short-Acting Injectable Opioid Treatment in AustraliaJake Rance, Vendula Belackova, James Bell, et al.
Pageof 34